Sellas Life Sciences Group Inc
Statements
Cash Flow
Sellas Life Sciences Group Inc (SLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -7.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -8.0 | -10 | -9.6 | -6.3 | 15 | -5.4 | -6.3 | -14 | -4.6 | -5.0 | -4.7 | -3.8 | -4.2 | -6.8 | -3.4 | -3.6 | 3.4 | -10 | -4.9 | -5.9 | -5.0 | -7.2 | -5.8 | -5.7 | -5.2 | -12 | -7.6 | -6.9 | -4.8 | -11 | -9.7 | -7.8 | -7.2 | -9.1 | -7.3 | -7.1 | -4.9 | -8.8 | -7.6 | -28 | |
| 0.6 | -1.2 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.1 | 0.1 | 9.1 | 0.1 | 0.1 | 0.1 | 2.8 | 0.1 | 0.1 | 0.1 | 0.0 | 0.8 | – | – | 1.3 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.6 | 0.4 | 0.2 | 0.2 | 0.2 | – | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.8 | 1.0 | 2.8 | |
| 1.2 | -4.5 | -4.8 | -2.3 | 1.3 | 12 | 0.0 | 1.5 | -0.6 | 6.6 | 0.2 | 0.1 | 0.1 | 2.9 | 0.1 | 0.2 | 0.1 | 0.3 | 0.2 | 0.4 | 0.4 | 1.1 | 10 | 0.4 | 0.6 | 0.4 | 0.5 | 0.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.1 | 1.9 | -0.6 | -1.0 | 0.3 | -10 | 0.3 | -1.0 | -11 | 1.4 | -0.8 | -0.8 | 0.2 | 0.3 | -2.9 | 0.7 | 0.6 | 7.2 | -9.1 | 0.1 | 0.8 | 0.5 | -0.8 | 2.3 | 0.6 | 3.6 | -1.7 | 0.6 | 1.7 | 2.7 | -1.8 | -1.6 | -1.2 | -0.9 | -3.9 | -1.4 | -0.9 | 2.1 | -1.4 | 0.8 | 0.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.5 | 0.0 | 0.0 | 3.0 | 5.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.1 | 1.1 | 0.0 | 0.0 | 0.0 | 1.8 | 1.8 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | -4.5 | -4.5 | -4.5 | -4.5 | -4.5 | -4.5 | -2.5 | -2.5 | -3.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.5 | 2.0 | 0.1 | 0.4 | 0.1 | – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 12 | 1.6 | 0.0 | 16 | 16 | -9.5 | -3.4 | 4.3 | 22 | -7.4 | 2.2 | 15 | 0.2 | 2.3 | 6.0 | 0.0 | – | – | 3.0 | 6.8 | – | – | – | – | – | – | 0.3 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.0 | 4.5 | 4.5 | -4.6 | -0.4 | -0.6 | -6.9 | -6.9 | -0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 17 | 1.6 | 20 | 5.7 | 1.1 | -16 | 4.7 | 4.2 | 14 | -0.1 | 2.2 | 15 | 0.2 | 2.3 | 6.3 | 0.0 | 8.5 | 24 | 3.0 | 6.8 | 2.2 | 0.1 | 0.0 | 23 | 0.1 | 0.9 | 19 | 0.0 | 0.1 | 3.4 | 27 | 0.4 | 20 | 0.0 | 24 | 4.2 | 26 | 32 | 44 | 39 | 141 | |
| 4.9 | -6.4 | 9.6 | -9.6 | -5.2 | -11 | -0.7 | -2.1 | 0.1 | -4.6 | -2.8 | 10 | -3.6 | -1.9 | -0.5 | -3.4 | 4.9 | 27 | -7.3 | 1.9 | -3.6 | -4.9 | -7.1 | 13 | -5.6 | -4.2 | 6.8 | -10 | -9.8 | -1.4 | 16 | -9.3 | 12 | -7.1 | 15 | -3.1 | 19 | 27 | 35 | 31 | 113 | |
| -12 | -8.0 | -10 | -9.6 | -6.3 | 15 | -5.4 | -6.3 | -14 | -4.6 | -5.0 | -4.7 | -3.8 | -4.2 | -6.8 | -3.4 | -3.6 | 3.4 | -10 | -4.9 | -5.9 | -5.0 | -7.2 | -5.8 | -5.7 | -5.2 | -12 | -7.6 | -9.9 | -10 | -11 | -9.7 | -7.8 | -7.2 | -9.1 | -7.3 | -7.1 | -4.9 | -8.8 | -7.6 | -28 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.